Simplified Report on Change of Equity

Hubei Jointown Pharmaceutical Group Co., Ltd.

Simplified Report on Change of Equity

Listed Company Name: Hubei Jointown Pharmaceutical Group Co., Ltd.

Stock Exchange: Shenzhen Stock Exchange

Stock Abbreviation: Jointown Pharmaceutical

Stock Code: 300966

Information Disclosure Obligor: Li Minglei

Domicile/Correspondence Address: Renmin Road [blank], Fancheng District, Xiangyang City, Hubei Province

Nature of Equity Change: Reduction of shares

Signing Date: July 6, 2026

Declaration of Information Disclosure Obligor

1. This report is prepared in accordance with the Securities Law of the People's Republic of China, the Administrative Measures for the Takeover of Listed Companies, and the Content and Format Standards for Information Disclosure by Companies Offering Securities to the Public No. 15 — Report on Change of Equity.

2. The information disclosure obligor has obtained the necessary authorization and approval to sign this report. Its fulfillment does not violate or conflict with any clauses in the articles of association or internal rules of the information disclosure obligor.

3. In accordance with the Securities Law of the People's Republic of China and the Administrative Measures for the Takeover of Listed Companies, this report fully discloses the changes in the shares held by the information disclosure obligor in Hubei Jointown Pharmaceutical Group Co., Ltd.

As of the date of signing this report, except for the information disclosed herein, the aforementioned information disclosure obligor has not increased or decreased its equity interest in Hubei Jointown Pharmaceutical Group Co., Ltd. through any other means.

1. This equity change is conducted based on the materials stated in this report. Except for the information disclosure obligor, no other person has been entrusted or authorized to provide information not contained in this report or to make any interpretation or explanation of this report.

2. The information disclosure obligor warrants that this report does not contain any false records, misleading statements, or major omissions, and assumes legal responsibility for its authenticity, accuracy, and completeness.

Table of Contents

Declaration of Information Disclosure Obligor 2

Section I Definitions 4

Section II Introduction to Information Disclosure Obligor 5

Section III Purpose of Equity Change 6

Section IV Method of Equity Change 7

Section V Transactions of Listed Company Shares in the Previous Six Months 9

Section VI Other Major Matters 10

Section VII Declaration of Information Disclosure Obligor 11

Section VIII Documents Available for Inspection 12

Appendix: Simplified Report on Change of Equity 13

Section I Definitions

Section II Introduction to Information Disclosure Obligor

I. Basic Information of the Information Disclosure Obligor